Patent Baristas® is an intellectual property news and commentary site featuring freshly brewed chat on patent and IP issues, particularly in the biosciences.
Patent Baristas, which receives over 60,000 visits and over 160,000 page views a month, has been designated as a Top 10 Source for IP Law and received TechnoLawyer’s Blawger of the Year award and the Blawg Review award for Best Blawg Theme.
Editor-in-Chief
Chief Barista Stephen Jenei (previously Stephen Albainy-Jenei) is the founder and owner of Patent Baristas®. He is also a patent attorney. Previously an equity member of a large regional law firm, he left big firm life to start his own law firm, Jenei LLC. Patent Baristas® is made possible by a generous grant from Jenei LLC.
When not serving up patent chat over a cup of java, he’s handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields for leading universities, research hospitals and research institutes, as well as biotechnology and pharmaceutical companies ranging from start-up to Fortune 500 companies.
Stephen works closely with biotechnology and emerging growth companies to brew up successful new business models, execute strategic intellectual property protection and litigation, and structure and negotiate technology transactions. Prior to founding Jenei LLC, Stephen was an equity member of a large law firm and before that the assistant general counsel and assistant director of Intellectual Property for a major university, ultimately serving as the acting director of intellectual property and university patent officer.
Stephen is a regular contributor to the Motley Fool and Drug Discovery News, writing commentary and analysis regarding recent business and legal news relating to the pharmaceutical and biotechnology industries. He regularly presents at CLE conferences around the country and is frequently found at Starbucks having a cup of joe.
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
Freshly brewed chat served up daily featuring biotechnology and pharmaceutical patent law news and commentary.
Stephen is designated as one of “America’s Leading Business Lawyers“, 2003-2011, in intellectual property by Chambers & Partners and is listed in Marquis’ Who’s Who in America, Sixty-First Edition 2007 . In addition, he has been designated a SuperLawyer Rising Star and is Peer Review Rated by Martindale-Hubbell®.
Stephen is a regular contributor to the Motley Fool and Drug Discovery News, writing commentary and analysis regarding recent business and legal news relating to the pharmaceutical and biotechnology industries. He regularly presents at CLE conferences around the country and is frequently found at Starbucks having a cup of joe.
